Literature DB >> 12687805

Is the left ventricular lateral wall the best lead implantation site for cardiac resynchronization therapy?

Maurizio Gasparini1, Massimo Mantica, Paola Galimberti, Monica Bocciolone, Luca Genovese, Maurizio Mangiavacchi, Ugo La Marchesina, Francesco Faletra, Catherine Klersy, Robert Coates, Edoardo Gronda.   

Abstract

Short-term hemodynamic studies consistently report greater effects of cardiac resynchronization therapy (CRT) in patients stimulated from a LV lateral coronary sinus tributary (CST) compared to a septal site. The aim of the study was to compare the long-term efficacy of CRT when performed from different LV stimulation sites. From October 1999 to April 2002, 158 patients (mean age 65 years, mean LVEF 0.29, mean QRS width 174 ms) underwent successful CRT, from the anterior (A) CST in 21 patients, the anterolateral (AL) CST in 37 patients, the lateral (L) CST in 57 patients, the posterolateral (PL) CST in 40 patients, and the middle cardiac vein (MCV) CST in 3 patients. NYHA functional class, 6-minute walk test, and echocardiographic measurements were examined at baseline, and at 3, 6, and 12 months. Comparisons were made among all pacing sites or between lateral and septal sites by grouping AL + L + PL CST as lateral site (134 patients, 85%) and A + MC CST as septal site (24 patients, 15%). In patients stimulated from lateral sites, LVEF increased from 0.30 to 0.39 (P < 0.0001), 6-minute walk test from 323 to 458 m (P < 0.0001), and the proportion of NYHA Class III-IV patients decreased from 82% to 10% (P < 0.0001). In patients stimulated from septal sites, LVEF increased from 0.28 to 0.41 (P < 0.0001), 6-minute walk test from 314 to 494 m (P < 0.0001), and the proportion of NYHA Class III-IV patients decreased from 75% to 23% (P < 0.0001). A significant improvement in cardiac function and increase in exercise capacity were observed over time regardless of the LV stimulation sites, either considered singly or grouped as lateral versus septal sites.

Entities:  

Mesh:

Year:  2003        PMID: 12687805     DOI: 10.1046/j.1460-9592.2003.00009.x

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  12 in total

Review 1.  Current and future role of cardiovascular magnetic resonance in cardiac resynchronization therapy.

Authors:  Francisco Leyva; Paul W X Foley
Journal:  Heart Fail Rev       Date:  2011-05       Impact factor: 4.214

2.  Transvenous access to the pericardial space: an approach to epicardial lead implantation for cardiac resynchronization therapy.

Authors:  Steven R Mickelsen; Hiroshi Ashikaga; Ranil DeSilva; Amish N Raval; Elliot McVeigh; Fred Kusumoto
Journal:  Pacing Clin Electrophysiol       Date:  2005-10       Impact factor: 1.976

3.  The interaction of interventricular pacing intervals and left ventricular lead position during temporary biventricular pacing evaluated by tissue Doppler imaging.

Authors:  R E Lane; A W C Chow; J Mayet; D P Francis; N S Peters; R J Schilling; D W Davies
Journal:  Heart       Date:  2007-02-03       Impact factor: 5.994

4.  [Optimal electrode placement. What to consider during implantation of a biventricular pacemaker?].

Authors:  C Butter; H-H Minden
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2009-09

5.  Cardiac Resynchronization Therapy for Heart Failure.

Authors:  Heather M. Ross; Dusan Z. Kocovic
Journal:  Curr Treat Options Cardiovasc Med       Date:  2004-10

Review 6.  Cardiac resynchronization therapy guided by cardiovascular magnetic resonance.

Authors:  Francisco Leyva
Journal:  J Cardiovasc Magn Reson       Date:  2010-11-09       Impact factor: 5.364

Review 7.  Potential uses of computed tomography for management of heart failure patients with dyssynchrony.

Authors:  Quynh A Truong; Udo Hoffmann; Jagmeet P Singh
Journal:  Crit Pathw Cardiol       Date:  2008-09

8.  Optimal left ventricular lead position assessed with phase analysis on gated myocardial perfusion SPECT.

Authors:  Mark J Boogers; Ji Chen; Rutger J van Bommel; C Jan Willem Borleffs; Petra Dibbets-Schneider; Bernies van der Hiel; Imad Al Younis; Martin J Schalij; Ernst E van der Wall; Ernest V Garcia; Jeroen J Bax
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-10-17       Impact factor: 9.236

9.  Cardiac resynchronization therapy in heart failure: recent advances and new insights.

Authors:  V Bhatia; R Bhatia; S Dhindsa; A Virk
Journal:  Indian Pacing Electrophysiol J       Date:  2003-07-01

10.  Cardiac Resynchronization Therapy Defibrillator Treatment in a Child with Heart Failure and Ventricular Arrhythmia.

Authors:  Hak Ju Kim; Sungkyu Cho; Woong-Han Kim
Journal:  Korean J Thorac Cardiovasc Surg       Date:  2016-08-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.